View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

SCHOTT Doubles Production Capacity for Polymer Syringes

SCHOTT has been expanding its manufacturing capacity for small size (1ml to 10 ml) SCHOTT TopPac® syringes in order to address the increasing worldwide demand for prefillable polymer syringes.

A new production line installed at the SCHOTT site in St Gallen, Switzerland, expanded the existing production capacity by 100% from April onwards. This enables SCHOTT to offer customers a greater degree of flexibility and ensure supply security.

SCHOTT is a pioneer in establishing the SCHOTT TopPac® product range as ready-to-fill syringes, which are made of Cyclic Olefin Copolymer (COC). Over the past 15 years, SCHOTT made significant investments to develop and industrialize COC material for pharmaceutical containers for injectable drugs.

COC is an inert material and the SCHOTT TopPac® syringe system is designed to be compatible with a broad range of drugs. The excellent barrier properties of the SCHOTT TopPac® syringe system allow long term storage of drugs even in small syringe sizes. In addition, SCHOTT TopPac® syringes have a glass-like transparency, and are break resistant and lightweight. SCHOTT TopPac® syringes are available in the range from 1ml to 50ml with cross linked silicone for optimal functionality.

Pharmaceutical companies benefit from the fact that SCHOTT TopPac® syringes are manufactured in clean rooms with a fully automated process starting from injection-molding to the final packaging in nest and tub. The syringes are sterilized and are ready for aseptic filling operations.

SCHOTT intends to achieve further growth in the field of polymer and glass syringes and also underscores its commitment to offer ideal product solutions to pharmaceutical companies, today and tomorrow.

The recent spike in market recalls for injectable drug products due to visible flaky particles associated with 'glass delamination' demonstrates the need to solve these...
Protecting medication from undesired interactions with the surrounding environment and preserving their efficacy during shelf life is one of the most pressing challenges for the...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology